Why the study?
Does intermittent positive inotrope infusion improve symptoms and functional status in patients with end-stage heart failure who are not transplant candidates?
Population
People with end-stage heart failure who are not candidates for transplant
Design
Review
Authors
Loading...
May offer palliative symptom relief in end-stage HF; leaves open whether benefits outweigh mortality in randomized trials.
Does intermittent positive inotrope infusion improve symptoms and functional status in patients with end-stage heart failure who are not transplant candidates?
Intermittent positive inotrope infusion in end-stage heart failure provides palliative benefits such as symptom relief and improved functional status, but at the cost of increased mortality.
Barbara Levine (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: